249
Views
37
CrossRef citations to date
0
Altmetric
Critical Care

Hump-nosed pit viper (Hypnale hypnale) envenoming causes mild coagulopathy with incomplete clotting factor consumption

, , , , , , , , & show all
Pages 527-531 | Received 31 Jan 2013, Accepted 28 May 2013, Published online: 23 Jul 2013

References

  • Kasturiratne A, Pathmeswaran A, Fonseka MMD, Lalloo DG, Brooker S, de Silva HJ. Estimates of disease burden due to land–snake bite in Sri Lankan hospitals. Southeast Asian J Trop Med Public Health 2005; 36:733–740.
  • Isbister GK. Procoagulant snake toxins: laboratory studies, diagnosis, and understanding snakebite coagulopathy. Semin Thromb Hemost 2009; 35:93–103.
  • Isbister G, Scrogie F, O’Leary M, Seldom M, Brown S, Lincz LF; ASP Investigators. Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). J Thromb Haemost 2010; 8: 2504–2513.
  • Warrell DA, Davidson NMD, Greenwood BM, Ormerod LD, Pope HM, Watkins BJ, Prentice CR. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med 1977; 46:33–62.
  • Lalloo D, Trevett A, Owens D, Minei J, Naraqi S, Saweri A, et al. Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni). Blood Coagul Fibrinolysis 1995; 6:65–72.
  • Sano-Martins I, Tomy S, Campolina D, Dias M, de Castro S, de Sousa-e-Silva M, et al. Coagulopathy following lethal and non- lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. QJM 2001; 94:551–559.
  • Maduwage K, Silva A, Manamendra-Arachchi K, Pethiyagoda R. A taxonomic revision of the South Asian pit viper genus Hypnale (Fitzinger). Zootaxa 2009; 2232:1–28.
  • Maduwage K, Isbister GK, Silva A, Bowatta S, Mendis S, Gawarammana I. Epidemiology and clinical effects of Hump-nosed pit viper (Genus: Hypnale) envenoming in Sri Lanka. Toxicon 2013; 61:11–15.
  • Ariaratnam CA, Thuraisingam V, Kularatne SAM, Sheriff MHR, Theakston RGD, de Silva A, Warrell DA. Frequent and potentially fatal envenoming byhump-nosed pit vipers (Hypnale hypnale and H. nepa) in Sri Lanka: lack of effective antivenom. Trans R Soc Trop Med Hyg 2008; 102:1120–1126.
  • Kularatne SA, Ratnatunga N. Severe systemic effects of Merrem's hump-nosed viper bite. Ceylon Med J 1999; 44:169–170.
  • de Silva A, Wijekoon ASB, Jayasena L, Abeysekara CK, Bao CX, Hutton RA, Warrell DA. Haemostatic dysfunction and acute renal failure following envenoming by Merrem's hump nosed viper (Hypnale hypnale) in Sri Lanka: First authenticated case. Trans R Soc Trop Med Hyg 1994; 88:209–212.
  • Maduwage K, Kularatne K, Wazil A, Gawarammana I. Coagulopathy, acute kidney injury and death following Hypnale zara envenoming – The first case report from Sri Lanka. Toxicon 2011; 58:641–643.
  • Premawardena AP, Seneviratne SL, Gunatilake SB, de Silva HJ. Excessive fibrinolysis: The coagulopathy following Merrem's hump-nosed viper (Hypnale hypnale) bites. Am J Trop Med Hyg 1998; 58:821–823.
  • Maduwage K, Hodgson WC, Konstantakopoulos N, O’Leary MA, Gawarammana I, Isbister GK. The in vitro toxicity of venoms from South Asian Hump-nosed pit vipers (Viperidae: Hypnale). J Venom Res 2011; 2:17–23.
  • Isbister GK, Maduwage K, Shahmy S, Mohamed F, Abeysinghe C, Karunathilake H, et al. Diagnostic 20 minute whole blood clotting test (WBCT20) in Russell's viper envenoming delays antivenom administration. QJM 2013 May 14. [Epub ahead of print] PMID: 23674721.
  • Joseph JK, Simpson ID, Menon NCS, Jose MP, Kulkarni KJ, Raghavendra GB, Warrell DA. First authenticated cases of life-threatening envenoming by the hump-nosed pit viper (Hypnale hypnale) in India. Trans R Soc Trop Med Hyg 2007; 101:85–90.
  • Isbister G, Shahmy S, Mohamed F, Abeysinghe C, Karunathilake H, Ariaratnam A. A randomised controlled trial of two infusion rates to decrease reactions to antivenom. PLoS One 2012; 7:e38739. Epub 2012 Jun 18
  • Sano-Martins IS, Fan HW, Castro SC, Tomy SC, Franca FO, Jorge MT, et al. Reliability of the simple 20 minute whole blood clotting test (WBCT20) as an indicator of low plasma fibrinogen concentration in patients envenomed by Bothrops snakes. Butantan Institute Antivenom Study Group. Toxicon 1994; 32:1045–1050.
  • Kulawickrama S, O’Leary MA, Hodgson WC, Brown SG, Jacoby T, Davern K, Isbister GK. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum. Toxicon 2010; 55:1510–1518.
  • Allen GE, Brown SG, Buckley NA, O’Leary MA, Page CB, Currie BJ, et al. Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming – Australian snakebite project (ASP-14). PLoS One 2012; 7:e53188.
  • Isbister GK, Scorgie FE, O’Leary MA, Seldon M, Brown SG, Lincz LF. Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). J Thromb Haemost 2010; 8:2504–2513.
  • Tan NH, Ponnudurai G, eds. Biochemical Characterization of Snake Venoms. Singapore: Venom & Toxin Research Group; 1992.
  • Tan CH, Sim SM, Gnanathasan CA, Fung S, Ponnudurai G, Pailoor J, Tan NH. Enzymatic and toxinological activities of Hypnale hypnale (hump-nosed pit viper) venom and its fractionation by ion exchange high performance liquid chromatography. J Venom Anim Toxins 2011; 17:473–485.
  • Isbister GK, Woods D, Alley S, O’Leary MA, Seldon M, Lincz LF. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom. Toxicon 2010; 56:75–85.
  • Isbister GK. Snake bite doesn't cause disseminated intravascular coagulation: Coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost 2010; 36:444–451.
  • Castro HC, Zingali RB, Albuquerque MG, Pujol-Luz M, Rodrigues CR. Snake venom thrombin-like enzymes: From reptilase to now. Cell Mol Life Sci 2004; 61:843–856.
  • Niewiarowski S, Kirby EP, Brudzynski TM, Stocker K. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors. Biochemistry 1979; 18:3570–3577.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.